Related Experiment Video
Updated: Aug 15, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
Incidence and predictors of distal symmetrical polyneuropathy in prediabetes: A 24-month prospective cohort study
Georgia Anastasiou1, Nikolaos Papanas2, Fotios Barkas3
1Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Insights
Prediabetes increases the risk of developing distal symmetrical polyneuropathy (DSPN). Age, male sex, smoking, central obesity, and insulin resistance are key predictors of DSPN in individuals with prediabetes.
Area of Science:
- Endocrinology
- Neurology
- Metabolic Syndrome
Background:
- Distal symmetrical polyneuropathy (DSPN) is a common diabetes complication, increasingly recognized in earlier dysglycemia stages.
- Prediabetes is linked to insulin resistance, central adiposity, and dyslipidemia, but DSPN incidence and cardiometabolic associations are understudied.
Purpose of the Study:
- To prospectively determine the incidence of DSPN in prediabetes patients.
- To identify predictors of incident DSPN within this population.
Main Methods:
- 160 prediabetes adults were followed for 24 months.
- DSPN assessed using neuropathy symptom score (NSS), neuropathy disability score (NDS), and vibration perception threshold (VPT).
- Multivariable regression analyzed predictors of incident DSPN.
Main Results:
- 27% of participants had DSPN at baseline; 9.8% developed DSPN over 24 months.
- Independent predictors included older age, male sex, smoking, larger waist circumference, and higher HOMA-IR (homeostatic model assessment of insulin resistance).
- Both baseline HOMA-IR and its change over time were significant predictors.
Conclusions:
- A 9.8% 24-month incidence of DSPN was observed in prediabetes.
- Age, male sex, smoking, central obesity, and insulin resistance (baseline and change) predict DSPN.
- Findings suggest potential for screening and prevention strategies in prediabetes.
Background:
Distal symmetrical polyneuropathy (DSPN) is a prevalent complication of diabetes, with emerging evidence of onset in earlier stages of dysglycemia. Prediabetes is characterized by insulin resistance, central adiposity, and dyslipidemia. Data on the incidence of DSPN in prediabetes and possible association with cardiometabolic factors remain limited.
Aim:
To prospectively assess the incidence of DSPN in individuals with prediabetes and identify possible predictors.
Methods:
Adults with prediabetes attending the Outpatient Lipid and Obesity Clinic at the University Hospital of Ioannina, Greece were enrolled and followed for a median of 24 months. DSPN was assessed longitudinally by the neuropathy symptom score (NSS), the neuropathy disability score (NDS) and the vibration perception threshold (VPT). Predictors of incident DSPN were examined using multivariable regression analysis.
Results:
Among 160 participants with prediabetes, 27 (16.9%) had DSPN at baseline. Among the remaining 133 participants,13 developed DSPN over 24 months (Interquartile Range [IQR] 20-27), yielding an incidence of 9.8%. In multivariable analysis, age (Odds Ratio [OR] per 1-year increase 1.11, 95% Confidence Interval [CI] 1.02-1.24), male sex (OR 1.07, 95% CI 1.01-3.28), current/previous smoking (OR 1.17, 95% CI 1.07-3.03),waist circumference (OR per 1-cm increase 1.04, 95% CI 1.02-1.28), homeostatic model assessment of insulin resistance (HOMA-IR) (OR per 0.1-increase 1.83, 95%CI 1.03-2.46), and ΔHOMA-IR (OR per 0.1 increase 1.46, 95% CI 1.07-2.46) were independently associated with incident DSPN (all p < 0.05).
Conclusions:
We observed a 9.8% 24-month incidence of DSPN in people with prediabetes. Age, male sex, smoking, central obesity, as well as insulin resistance at baseline and change over time were independent predictors of incident DSPN. These findings may have screening and preventive implications if confirmed by larger studies.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Neuropathy
Diabetes: Symptoms, Diagnosis, and Complications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Nephropathy
Type I Diabetes III: Clinical Manifestations